Benitec Biopharma Inc (BNTC) insider trading
Every open-market stock purchase and sale by Benitec Biopharma Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Insiders bought $22.4M over the last 12 months (3 buys).
- Last insider buy: Suvretta Capital Management LLC (Insider), $884K, 9 months ago.
Last 12 months: insiders bought $22.4M (3 buys) and sold $0 (0 sales). Last close $10.55 on Jun 4, 2026.
Recent BNTC insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Jun 29, 2026 | J Kevin Buchi (Insider) | Sold (not open market) | — |
| May 26, 2026 | David Matthew Friedman (Insider) | Bought (not open market) | — |
| Jan 22, 2026 | Sharon Mates (Director) | Bought (not open market) | — |
| Dec 29, 2025 | Suvretta Capital Management LLC (Insider) | Bought | $884K |
| Dec 29, 2025 | Suvretta Capital Management LLC (Insider) | Bought | $156K |
| Dec 26, 2025 | Suvretta Capital Management LLC (Insider) | Bought | $188K |
| Dec 26, 2025 | Suvretta Capital Management LLC (Insider) | Bought | $33K |
| Dec 23, 2025 | Suvretta Capital Management LLC (Insider) | Bought | $547K |
| Dec 23, 2025 | Suvretta Capital Management LLC (Insider) | Bought | $95.1K |
| Dec 22, 2025 | Suvretta Capital Management LLC (Insider) | Bought | $201K |
| Dec 22, 2025 | Suvretta Capital Management LLC (Insider) | Bought | $34.9K |
| Dec 19, 2025 | Suvretta Capital Management LLC (Insider) | Bought | $160K |
| Dec 19, 2025 | Suvretta Capital Management LLC (Insider) | Bought | $27.9K |
| Dec 18, 2025 | Suvretta Capital Management LLC (Insider) | Bought | $97.8K |
| Dec 18, 2025 | Suvretta Capital Management LLC (Insider) | Bought | $17K |
| Dec 1, 2025 | J Kevin Buchi (Director) | Bought (not open market) | — |
| Dec 1, 2025 | Sharon Mates (Director) | Bought (not open market) | — |
| Dec 1, 2025 | Kishan Mehta (Director) | Bought (not open market) | — |
| Dec 1, 2025 | Edward F Smith (Director) | Bought (not open market) | — |
| Dec 1, 2025 | Peter Francis (Director) | Bought (not open market) | — |
| Nov 18, 2025 | Megan Boston (CFO) | Bought (not open market) | — |
| Nov 18, 2025 | Sophie Mukadam (COO) | Bought (not open market) | — |
| Nov 18, 2025 | Jerel A. Banks (CEO) | Bought (not open market) | — |
| Nov 7, 2025 | Suvretta Capital Management LLC (Insider) | Bought | $10.1M |
| Nov 7, 2025 | Suvretta Capital Management LLC (Insider) | Bought | $9.9M |
Who's trading BNTC
- J Kevin Buchi, Director: other filings, last Jun 29, 2026
- David Matthew Friedman, Insider: other filings, last May 26, 2026
- Sharon Mates, Director: other filings, last Jan 22, 2026
- Suvretta Capital Management LLC, Insider: bought $22.4M (14 buys), last Dec 29, 2025
- Kishan Mehta, Director: other filings, last Dec 1, 2025
- Peter Francis, Director: other filings, last Dec 1, 2025
- Edward F Smith, Director: other filings, last Dec 1, 2025
- Sophie Mukadam, COO: other filings, last Nov 18, 2025
- Jerel A. Banks, CEO: other filings, last Nov 18, 2025
- Megan Boston, Director: other filings, last Nov 18, 2025
Get free alerts when an insider at Benitec Biopharma Inc files a new trade →